ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

AXSM Axsome Therapeutics Inc

76.00
4.29 (5.98%)
시간외 단일가
최종 업데이트: 18:27:40
15분 지연
기업명 주식 심볼 시장 주식 타입
Axsome Therapeutics Inc AXSM 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
4.29 5.98% 76.00 18:27:40
개장가 저가 고가 종가 전일 종가
71.71
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
15/04/202420:00GLOBEAxsome Therapeutics Highlights Innovative Neuroscience..
10/04/202420:00GLOBEAxsome Therapeutics to Report First Quarter 2024 Financial..
01/04/202420:00GLOBEAxsome Therapeutics Initiates ENGAGE Phase 3 Trial of..
25/03/202420:00GLOBEAxsome Therapeutics Announces Results of CRESCENDO..
25/03/202419:30GLOBEAxsome Therapeutics Announces AXS-12 Achieves Primary..
19/03/202420:00GLOBEAxsome Therapeutics Initiates PARADIGM Phase 3 Trial of..
05/03/202421:00GLOBEAxsome Therapeutics to Present at the Leerink Partners..
01/03/202408:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202407:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202421:00GLOBEAxsome Therapeutics to Present at the TD Cowen 44th Annual..
23/02/202422:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/02/202421:05EDGAR2Form 8-K - Current report
20/02/202421:00GLOBEAxsome Therapeutics Reports Fourth Quarter and Full Year..
20/02/202419:37IHMARKETNEWSMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil..
15/02/202405:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/01/202421:00GLOBEAxsome Therapeutics to Report Fourth Quarter and Full Year..
08/01/202421:10EDGAR2Form 8-K - Current report
04/01/202421:11EDGAR2Form 8-K - Current report
04/01/202421:00GLOBEAxsome Therapeutics Provides Preliminary Fourth Quarter and..
11/12/202321:00GLOBEAxsome Therapeutics Presents New Data and Post-Hoc Analyses..
08/12/202306:05EDGAR2Form 8-K - Current report
07/12/202321:00GLOBEAxsome Therapeutics Hosts Solriamfetol Virtual Investor..
22/11/202321:00GLOBEAxsome Therapeutics to Host Solriamfetol Virtual Investor..
21/11/202321:00GLOBEAxsome Therapeutics to Present at the Piper Sandler 35th..
07/11/202306:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202321:05EDGAR2Form 8-K - Current report
06/11/202321:00GLOBEAxsome Therapeutics Reports Third Quarter 2023 Financial..
06/11/202320:54IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
02/11/202320:00GLOBEAxsome Therapeutics and the Global Alzheimer’s Disease..
31/10/202320:00GLOBEAxsome Therapeutics to Present at Upcoming Investor..
24/10/202320:00GLOBEAxsome Therapeutics Presents Results of the ACCORD trial of..
12/10/202306:03EDGAR2Form 8-K - Current report
11/10/202320:00GLOBEAxsome Therapeutics Appoints Dr. Sue Mahony to its Board of..
10/10/202320:00GLOBEAxsome Therapeutics to Report Third Quarter 2023 Financial..
02/10/202320:00GLOBEAxsome Therapeutics Joins the National Alliance on Mental..
21/09/202320:00GLOBEAxsome Therapeutics Joins the Global Narcolepsy Community in..
16/09/202307:32EDGAR2Form 144 - Report of proposed sale of securities
16/09/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202320:03GLOBEAxsome Therapeutics Highlights Commitment to Innovating..
05/09/202320:00GLOBEAxsome Therapeutics to Present at Three Upcoming Investor..
15/08/202320:45EDGAR2Form 8-K - Current report
08/08/202306:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202305:02EDGAR2Form 8-K - Current report
07/08/202320:00GLOBEAxsome Therapeutics Reports Second Quarter 2023 Financial..
05/08/202305:49EDGAR2Form 8-K - Current report
12/07/202320:00GLOBEAxsome Therapeutics to Report Second Quarter 2023 Financial..
08/07/202305:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/07/202321:21EDGAR2Form 8-K - Current report
07/07/202320:00GLOBEAxsome Therapeutics Initiates FOCUS Phase 3 Trial of..

최근 히스토리

Delayed Upgrade Clock